Sanara MedTech (SMTI) Debt to Equity (2016 - 2025)
Historic Debt to Equity for Sanara MedTech (SMTI) over the last 12 years, with Q3 2025 value amounting to $7.33.
- Sanara MedTech's Debt to Equity rose 86995.9% to $7.33 in Q3 2025 from the same period last year, while for Sep 2025 it was $7.33, marking a year-over-year increase of 86995.9%. This contributed to the annual value of $0.78 for FY2024, which is 25825.29% up from last year.
- Latest data reveals that Sanara MedTech reported Debt to Equity of $7.33 as of Q3 2025, which was up 86995.9% from $1.25 recorded in Q2 2025.
- In the past 5 years, Sanara MedTech's Debt to Equity ranged from a high of $7.33 in Q3 2025 and a low of $0.22 during Q4 2023
- For the 3-year period, Sanara MedTech's Debt to Equity averaged around $1.37, with its median value being $0.76 (2024).
- In the last 5 years, Sanara MedTech's Debt to Equity skyrocketed by 24403.19% in 2024 and then surged by 86995.9% in 2025.
- Quarter analysis of 3 years shows Sanara MedTech's Debt to Equity stood at $0.22 in 2023, then skyrocketed by 258.25% to $0.78 in 2024, then soared by 841.51% to $7.33 in 2025.
- Its last three reported values are $7.33 in Q3 2025, $1.25 for Q2 2025, and $1.18 during Q1 2025.